The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer.
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
Other Relationship - Steba Biotech
 
Daniel D. Sjoberg
Consulting or Advisory Role - OPKO Diagnostics
 
Quinlan Demac
No Relationships to Disclose
 
Catriona ODea
No Relationships to Disclose
 
Marlena McGill
No Relationships to Disclose
 
Andrew Tracey
No Relationships to Disclose
 
Lucas Nogueira
Consulting or Advisory Role - Bayer
Speakers' Bureau - Astellas Pharma; Bayer
 
Andrew Vickers
Stock and Other Ownership Interests - OPKO Health
Consulting or Advisory Role - Insightec; OPKO Diagnostics; Steba Biotech
Patents, Royalties, Other Intellectual Property - I am named on a patent for a statistical method to detect prostate cancer. This method has been commercialized by Opko as the "4Kscore". I receive royalties from sales of the 4Kscore.
Travel, Accommodations, Expenses - OPKO Health
 
Connie Estes
No Relationships to Disclose
 
Samson Fine
No Relationships to Disclose
 
Oguz Akin
No Relationships to Disclose
 
John Mulhall
No Relationships to Disclose
 
Jaspreet Sandhu
No Relationships to Disclose
 
Brett Stewart Carver
No Relationships to Disclose
 
Vincent Paul Laudone
No Relationships to Disclose
 
Behfar Ehdaie
No Relationships to Disclose
 
Avigdor Joshua Scherz
No Relationships to Disclose
 
Peter T. Scardino
Consulting or Advisory Role - OPKO Diagnostics
 
James Andrew Eastham
Stock and Other Ownership Interests - 3D Biopsy